MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB

NCT02643654 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: MABp1
DRUG: Placebo

Sponsor

Evangelos J. Giamarellos-Bourboulis, M.D.

Collaborators

[object Object]